Avoid cell-to-cell disease transmission in ALS patient-based cellular model
Efficacy in transgenic TDP-43 mouse model and in ALS patient-based cellular model
Synthesis and first biological profile of the inhibitors
Category: Publications
Access Molefy Pharma’s scientific publications focused on ALS research, neurodegenerative diseases, and pharmaceutical innovation.